Swathi Ramakrishnan, Ph.D.
Affiliations: | 2014 | Roswell Park . Cancer Pathology and Prevention (Experimental) | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
OncologyGoogle:
"Swathi Ramakrishnan"Parents
Sign in to add mentor| Roberto Pili | grad student | 2014 | SUNY Buffalo | |
| (Biological role of selective histone deacetylases in clear cell renal cell carcinoma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Athans S, Krishnan N, Ramakrishnan S, et al. (2022) STAG2 expression is associated with adverse survival outcomes and regulates cell phenotype in muscle-invasive bladder cancer. Cancer Research Communications. 2: 1129-1143 |
| Mastri M, Ramakrishnan S, Shah SD, et al. (2021) Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartment. American Journal of Clinical and Experimental Urology. 9: 416-434 |
| Krishnan N, Aquila L, Vickers SL, et al. (2020) Abstract A22: STAG2, a novel genetic regulator of bladder cancer Clinical Cancer Research. 26 |
| Ramakrishnan S, Peng X, Gomez EC, et al. (2020) Abstract B087: Role of GATA-4-Androgen-AR axis in prostate cancer from African American men Cancer Epidemiology, Biomarkers & Prevention |
| Elbanna M, Orillion AR, Damayanti NP, et al. (2019) Dual inhibition of angiopoietin-TIE2 and MET alters the tumor microenvironment and prolongs survival in a metastatic model of renal cell carcinoma. Molecular Cancer Therapeutics |
| Bunch B, Krishnan N, Greenspan RD, et al. (2019) TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC). Cell Cycle (Georgetown, Tex.). 1-12 |
| Ramakrishnan S, Granger V, Rak M, et al. (2019) Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death and Differentiation |
| Ramakrishnan S, Peng X, Qi Q, et al. (2018) Abstract B72: DNA methylation and genetic alterations contribute to aggressive prostate cancer in African American men Cancer Epidemiology, Biomarkers & Prevention. 27 |
| Ramakrishnan S, Hu Q, Krishnan N, et al. (2017) Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer. Cell Death & Disease. 8: 3217 |
| Wei L, Chintala S, Ciamporcero E, et al. (2016) Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts. Oncotarget |